Potent and selective kappa opioid receptor antagonists have been derived from the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of pure opioid receptor antagonists. In order to determine if the 3-hydroxyphenyl and/or the piperidine amino groups are required for obtaining the pure opioid antagonists, (3R)-7-hydroxy-N-[(1S)-2-methy1-1(piperidine- 1-ylmethyl) propyl]-1,2,3,4-tetrahydroiosquinoline-3-carboxamide (1), which does not have a 4-(3-hydroxyphenyl) group, and (3R)-N(1R)-1-(cydohexylmethyl)-2-methylpropy1]-7-hydroxy-1,2,3,4-tetrahydroiso-quinoline-3-carboxamide (2), which does not have a 4-hydroxylphenyl or a piperidine amino group, were synthesized and evaluated for their [S-35]GTP gamma S binding properties at the mu, delta, and kappa opioid receptors. Surprisingly compound 1 remained a pure opioid antagonist with a K-e = 6.80 nM at the kappa opioid receptor and is 21- and 441-fold selective for the kappa receptor relative to the mu and 6 opioid receptors, respectively. Even more unexpected and novel is the finding that 2 has a K-e = 0.14 nM at kappa and is 1730- and 4570-fold selective for kappa relative to the mu and delta opioid receptors, respectively.
Simple tetrahydroisoquinolines are potent and selective kappa opioid receptor antagonists
Kormos, C. M., Ondachi, P. W., Runyon, S. P., Thomas, J. B., Mascarella, S. W., Decker, A. M., Navarro, H. A., & Carroll, F. I. (2017). Simple tetrahydroisoquinolines are potent and selective kappa opioid receptor antagonists. ACS Medicinal Chemistry Letters, 8(7), 742-745. https://doi.org/10.1021/acsmedchemlett.7b00115
Abstract
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Meet the Experts
View All ExpertsRecent Publications
Article
What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders
Article
Grandi Byen-supporting child growth and development through integrated, responsive parenting, nutrition and hygiene
Article
Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions
Patent